Stockscreener 앱 받기
7.83
0.13%
-0.010
시장 영업 전:
7.83
전일 마감가:
$7.84
열려 있는:
$7.92
하루 거래량:
32,673
Relative Volume:
0.87
시가총액:
$53.10M
수익:
-
순이익/손실:
$-71.37M
주가수익비율:
-0.7265
EPS:
-10.7782
순현금흐름:
$-46.62M
1주 성능:
-3.09%
1개월 성능:
-2.49%
6개월 성능:
-49.29%
1년 성능:
-44.27%
1일 변동 폭
$7.80
$8.03
1주일 범위
$7.785
$8.285
52주 변동 폭
$5.67
$42.79
인스틸 바이오 Stock (TIL) Company Profile
명칭
Instil Bio Inc
전화
(972) 499-3350
주소
3963 MAPLE AVENUE, DALLAS
Compare TIL vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TIL
Instil Bio Inc
|
7.83 | 53.10M | 0 | -71.37M | -46.62M | -10.78 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
인스틸 바이오 Stock (TIL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2026-01-06 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-01-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-11-04 | 개시 | JMP Securities | Mkt Perform |
| 2024-04-12 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-11-01 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2022-11-01 | 다운그레이드 | Truist | Buy → Hold |
| 2021-08-13 | 개시 | Robert W. Baird | Outperform |
| 2021-04-13 | 개시 | Cowen | Outperform |
| 2021-04-13 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-04-13 | 개시 | Truist | Buy |
모두보기
인스틸 바이오 주식(TIL)의 최신 뉴스
TIL Technical Analysis | Trend, Signals & Chart Patterns | INSTIL BIO INC (NASDAQ:TIL) - ChartMill
Key Growth Drivers | Instil Bio posts 40.9% EPS beat topping analyst estimatesConsensus Forecast - Newser
(TIL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
[ARS] Instil Bio, Inc. SEC Filing - Stock Titan
Instil Bio (NASDAQ: TIL) sets 2026 vote and replaces Deloitte - Stock Titan
TIL Instil Bio delivers strong Q4 2025 EPS upside versus analyst estimates, shares edge slightly higher in today’s session.Community Volume Signals - Newser
TIL (Instil Bio Inc.) posts narrower Q4 2025 loss than consensus estimates, shares dip modestly in muted market reaction.Viral Trade Signals - Cổng thông tin điện tử Tỉnh Sơn La
Instil Bio, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
TIL Ownership | INSTIL BIO INC (NASDAQ:TIL) - ChartMill
Instil Bio (TIL) Stock Wall Street Rating (+0.11%) 2026-04-16Community Trade Ideas - Xã Thanh Hà
Responsive Playbooks and the TIL Inflection - Stock Traders Daily
Instil Bio (TIL) Price Target Increased by 24.53% to 67.32 - MSN
Breakout Move: Is Instil Bio Inc gaining market share2026 Setups & Community Verified Watchlist Alerts - baoquankhu1.vn
Will Instil Bio (TIL) Stock Outperform S&P 500 | Price at $7.99, Down 0.50%High Conviction Picks - Newser
Instil Bio appoints RSM US as new auditor, replacing Deloitte & Touche - Investing.com India
Instil Bio appoints RSM US as new auditor, replacing Deloitte & Touche By Investing.com - Investing.com South Africa
Instil Bio (TIL) replaces Deloitte with RSM as independent auditor - Stock Titan
Understanding the Setup: (TIL) and Scalable Risk - Stock Traders Daily
TIL Technical Analysis & Stock Price Forecast - Intellectia AI
TIL PE Ratio & Valuation, Is TIL Overvalued - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Instil Bio Inc expected to post a loss of 59 cents a shareEarnings Preview - TradingView
Aug Levels: Is Instil Bio Inc forming bullish engulfing patterns2026 Institutional & Capital Efficient Trading Techniques - baoquankhu1.vn
Instil Bio Faces Heightened Cybersecurity Threats as Data Breach Risks Jeopardize Clinical Trials and Long-Term Strategy - TipRanks
Instil Bio, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Instil Bio (NASDAQ: TIL) ends all R&D and warns on going concern - Stock Titan
Instil Bio 2025 10-K: $(71.4)M net loss, $(10.70) loss per share - TradingView
Instil Bio Q4 net loss per share narrows - TradingView
BRIEF-Instil Bio Q4 Basic EPS USD -1.21 - TradingView
[8-K] Instil Bio, Inc. Reports Material Event - Stock Titan
Instil Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - The Globe and Mail
Bull Run: What analysts say about Instil Bio Inc stockMarket Volume Summary & Accurate Buy Signal Alerts - baoquankhu1.vn
The Technical Signals Behind (TIL) That Institutions Follow - Stock Traders Daily
If You Invested $1,000 in Instil Bio, Inc. (TIL) - Stock Titan
Instil Bio, Inc.: Fundamental Analysis and Financial Ratings | 5GT0 | US45783C2008 - marketscreener.com
Bond Watch: Can Instil Bio Inc scale operations efficiently2026 Movers & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Precision Trading with Instil Bio Inc. (TIL) Risk Zones - Stock Traders Daily
TIL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Technical Reactions to TIL Trends in Macro Strategies - Stock Traders Daily
Instil Bio Inc expected to post a loss of $2.03 a shareEarnings Preview - TradingView
Does Instil Bio Inc. meet Warren Buffett’s criteriaEarnings Growth Report & Weekly Setup with ROI Potential - mfd.ru
Trading the Move, Not the Narrative: (TIL) Edition - Stock Traders Daily
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc.TIL - PR Newswire
Technical Analysis: Does Instil Bio Inc. meet Warren Buffett’s criteriaQuarterly Earnings Report & Growth Focused Investment Plans - mfd.ru
BML Investment Partners discloses 9.5% Instil Bio (TIL) stake in amended 13G - Stock Titan
Market Leaders: Is Instil Bio Inc gaining market shareBreakout Watch & Advanced Technical Signal Analysis - baoquankhu1.vn
(TIL) Volatility Zones as Tactical Triggers - Stock Traders Daily
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, ... - Bluefield Daily Telegraph
TIL Should I Buy - Intellectia AI
Price-Driven Insight from (TIL) for Rule-Based Strategy - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Encourages Instil Bio, Inc. (TIL) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
인스틸 바이오 (TIL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):